Author:
Pai Sher-Lu,Smith Michael A.,Beam W. Brian,Harbell Monica W.
Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Centers for Disease Control and Prevention. National Diabetes Statistics Report: estimates of diabetes and its burden in the United States. 2022. https://www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed September 1, 2023.
2. Centers for Disease Control and Prevention. Prevalence of both diagnosed and undiagnosed diabetes. 2022. https://www.cdc.gov/diabetes/data/statistics-report/diagnosed-undiagnosed-diabetes.html. Accessed September 1, 2023.
3. Stierman B, Afful J, Carroll MD, Chen T, Davy O, Fink S, et al. National Health and Nutrition Examination Survey: 2017–March 2020 prepandemic data, files—development of files and prevalence estimates for selected health outcomes. Natl Health Stat Rep. 2021;158:1–21. https://doi.org/10.15620/cdc:106273.
4. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 3. Prevention or delay of type 2 diabetes and associated comorbidities: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl):S41–8. https://doi.org/10.2337/dc23-S003.
5. Maki KC, Kirkpatrick CF, Allison DB, Gadde KM. Pharmacotherapy for obesity: recent evolution and implications for cardiovascular risk reduction. Expert Rev Endocrinol Metab. 2023;1–13. https://doi.org/10.1080/17446651.2023.2209176.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Implications of GLP-1 agonist use on airway management;The American Journal of Emergency Medicine;2024-08